🇺🇸 Inetetamab in United States

1 US adverse-event reports

Marketing authorisation

FDA

Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Window: 27 March 2025 – 27 March 2026
Total reports: 1

Most-reported reactions

Myelosuppression — 1 report (100%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Inetetamab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Inetetamab in United States?

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.